IRIS Accounts Production v25.1.0.734 06969099 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 329 9437 3250 27620 8512 18512 5591 329 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069690992023-07-31069690992024-07-31069690992023-08-012024-07-31069690992022-07-31069690992022-08-012023-07-31069690992023-07-3106969099ns15:EnglandWales2023-08-012024-07-3106969099ns14:PoundSterling2023-08-012024-07-3106969099ns10:Director12023-08-012024-07-3106969099ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3106969099ns10:SmallEntities2023-08-012024-07-3106969099ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3106969099ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3106969099ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3106969099ns10:FullAccounts2023-08-012024-07-3106969099ns10:OrdinaryShareClass12023-08-012024-07-3106969099ns10:OrdinaryShareClass22023-08-012024-07-3106969099ns10:Director2422023-07-3106969099ns10:Director2422022-07-3106969099ns10:Director2422023-08-012024-07-3106969099ns10:Director2422022-08-012023-07-3106969099ns10:Director2422024-07-3106969099ns10:Director2422023-07-3106969099ns5:CurrentFinancialInstruments2024-07-3106969099ns5:CurrentFinancialInstruments2023-07-3106969099ns5:ShareCapital2024-07-3106969099ns5:ShareCapital2023-07-3106969099ns5:RetainedEarningsAccumulatedLosses2024-07-3106969099ns5:RetainedEarningsAccumulatedLosses2023-07-3106969099ns10:RegisteredOffice2023-08-012024-07-3106969099ns10:OrdinaryShareClass12024-07-3106969099ns10:OrdinaryShareClass22024-07-3106969099ns10:Director22023-08-012024-07-31069690991ns10:Director12023-07-31069690991ns10:Director12022-07-31069690991ns10:Director12023-08-012024-07-31069690991ns10:Director12022-08-012023-07-31069690991ns10:Director12024-07-31069690991ns10:Director12023-07-31
REGISTERED NUMBER: 06969099 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st July 2024

for

T A Medical Ltd

T A Medical Ltd (Registered number: 06969099)






Contents of the Financial Statements
for the Year Ended 31st July 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


T A Medical Ltd (Registered number: 06969099)

Balance Sheet
31st July 2024

31.7.24 31.7.23
Notes £    £   
CURRENT ASSETS
Cash at bank 29,112 32,766

CREDITORS
Amounts falling due within one year 4 6,272 329
NET CURRENT ASSETS 22,840 32,437
TOTAL ASSETS LESS CURRENT
LIABILITIES

22,840

32,437

CAPITAL AND RESERVES
Called up share capital 5 100 100
Retained earnings 22,740 32,337
SHAREHOLDERS' FUNDS 22,840 32,437

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29th April 2025 and were signed on its behalf by:





Dr T Akintewe - Director


T A Medical Ltd (Registered number: 06969099)

Notes to the Financial Statements
for the Year Ended 31st July 2024

1. COMPANY INFORMATION

T A Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06969099

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Going concern
At the time of approving the financial statements, the director has confirmed that they will continue to support the company and ensure it has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Directors' current accounts 5,591 329
Accrued expenses 681 -
6,272 329

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.24 31.7.23
value: £    £   
60 Ordinary A 1 60 60
40 Ordinary B 1 40 40
100 100

T A Medical Ltd (Registered number: 06969099)

Notes to the Financial Statements - continued
for the Year Ended 31st July 2024

5. CALLED UP SHARE CAPITAL - continued

The Ordinary A shares rank equally in terms of voting rights, rights to participate in all dividend distributions and rights to participate in any capital distribution on winding up.

The Ordinary B shares do not hold any voting rights and dividend rights are at the discretion of the Ordinary A Shareholders.

The A and B Shares rank pari passu in respect of capital distribution rights.

6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st July 2024 and 31st July 2023:

31.7.24 31.7.23
£    £   
Dr T Akintewe and Mrs M Akintewe
Balance outstanding at start of year (329 ) (9,437 )
Amounts advanced 3,250 27,620
Amounts repaid (8,512 ) (18,512 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,591 ) (329 )

The loan is repayable on demand and no interest was charged during the year.

7. CONTROL

The ultimate controlling party is Dr Akintewe by virtue of holding 100% of the voting share capital.